Mohammed Tikly to Developing Countries
This is a "connection" page, showing publications Mohammed Tikly has written about Developing Countries.
Connection Strength
0,874
-
Biologic therapy for rheumatoid arthritis in developing countries--a place for non-TNF inhibitors as first-line treatment? Rheumatology (Oxford). 2015 Feb; 54(2):208-9.
Score: 0,369
-
Lupus in the developing world--is it any different? Best Pract Res Clin Rheumatol. 2008 Aug; 22(4):643-55.
Score: 0,249
-
Rheumatoid arthritis in the developing world. Best Pract Res Clin Rheumatol. 2003 Oct; 17(5):863-75.
Score: 0,178
-
Living with systemic lupus erythematosus in the developing world. Rheumatol Int. 2018 09; 38(9):1601-1613.
Score: 0,030
-
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. BMC Musculoskelet Disord. 2015 May 29; 16:130.
Score: 0,025
-
Rheumatoid arthritis in the developing world: stepping up to the challenge. Clin Rheumatol. 2014 Sep; 33(9):1195-6.
Score: 0,023